ARTICLE | Company News
Icogen other research news
April 29, 2002 7:00 AM UTC
Icogen received a $100,000 Phase 1 SBIR grant from the National Institute of Allergy and Infectious Diseases to develop its high throughput GPCR Activator Screening Technology to identify chemokine re...